HighCo Logo

HighCo

Data marketing firm offering digital solutions for brands & retailers to influence shopper behavior.

HCO | PA

Overview

Corporate Details

ISIN(s):
FR0000054231
LEI:
969500FYLNRXCJ348W66
Country:
France
Address:
365 AVENUE ARCHIMEDE, 13290 AIX-EN-PROVENCE
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HighCo is a data marketing and communication company founded in 1990 that specializes in providing innovative digital solutions for brands and retailers. The company supports clients in accelerating the transformation of retail by influencing consumer behavior across the entire engagement chain, from initial contact to transaction. HighCo offers integrated marketing solutions that include shopper activation, management of traditional and digital promotional offers, and drive-to-store strategies. Its mission is to leverage data to help brands and retailers enhance the consumer experience and purchasing decisions.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-03 15:22
Transaction in Own Shares
HighCo : transactions sur actions propres du 27 au 31 octobre 2025
French 250.9 KB
2025-10-06 09:35
Transaction in Own Shares
HighCo : Transactions sur actions propres du 29 septembre au 3 octobre 2025
French 246.8 KB
2025-09-02 14:46
Declaration of Voting Results & Voting Rights Announcements
HighCo : Déclaration mensuelle des droits de vote
French 260.8 KB
2025-09-02 14:46
Declaration of Voting Results & Voting Rights Announcements
HighCo: Shareholding
English 273.5 KB
2025-08-04 11:12
Declaration of Voting Results & Voting Rights Announcements
HighCo : Déclaration mensuelle des droits de vote
French 261.2 KB
2025-08-04 11:12
Declaration of Voting Results & Voting Rights Announcements
HighCo : Shareholding
English 273.5 KB
2025-06-17 16:37
Major Shareholding Notification
Franchissement de seuil
French 77.4 KB
2025-06-17 08:00
M&A Activity
HighCo: EXCLUSIVE NEGOTIATIONS WITH SMP TO ACQUIRE ITS PROMOTION (SOGEC) AND MA…
English 245.2 KB
2025-06-17 08:00
M&A Activity
HIGHCO : NÉGOCIATIONS EXCLUSIVES AVEC SMP POUR L’ACQUISITION DES ACTIVITÉS PROM…
French 237.6 KB
2025-06-06 15:01
Declaration of Voting Results & Voting Rights Announcements
HighCo : Shareholding
English 214.9 KB
2025-06-06 15:01
Declaration of Voting Results & Voting Rights Announcements
HighCo : Déclaration mensuelle des droits de vote
French 201.8 KB
2025-06-05 18:00
Notice of Dividend Amount
HighCo: HIGHCO ANNOUNCES COMPLETION OF SALE OF HIGH CONNEXION
English 236.4 KB
2025-06-05 18:00
Earnings Release
HIGHCO : HIGHCO ANNONCE LA RÉALISATION DE LA CESSION DE HIGH CONNEXION
French 229.3 KB
2025-05-20 15:59
Post-Annual General Meeting Information
HIGHCO : COMPTE-RENDU DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 19 MAI 2025
French 203.8 KB
2025-05-07 10:14
Declaration of Voting Results & Voting Rights Announcements
HighCo : Déclaration mensuelle des droits de vote au 30-04-2025
French 201.6 KB

Automate Your Workflow. Get a real-time feed of all HighCo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HighCo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HighCo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Advancing high-grade copper and precious metal projects from discovery to production.
Canada COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.